CADL - Candel Therapeutics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
10/15/24 17:59	10/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Aguilar-Cordova Estuardo	MA	T		S.m	-244	6.03	-40	-1	6,054	D
10/3/24 18:19	10/1/24	CADL	Health	BioPrd	Biological Products, (No Diag	Aguilar-Cordova Estuardo	MA	T		S.m	-243	6.93	-35	-1	6,094	D
7/19/24 08:31	7/17/24	CADL	Health	BioPrd	Biological Products, (No Diag	Tyagarajan Seshu	MA	O	CTO	S	-96	6.47	-15	-9	146	D
7/19/24 08:29	7/17/24	CADL	Health	BioPrd	Biological Products, (No Diag	Tak Paul Peter	MA	DO	CEO	S	-146	6.47	-23	-6	331	D
7/19/24 08:28	7/17/24	CADL	Health	BioPrd	Biological Products, (No Diag	Schoch Charles	MA	O	See Rema	S	-64	6.47	-10	-14	63	D
7/19/24 08:26	7/17/24	CADL	Health	BioPrd	Biological Products, (No Diag	Nichols William Garrett	MA	O	Chief Me	S	-70	6.47	-11	-9	114	D
7/19/24 08:24	7/17/24	CADL	Health	BioPrd	Biological Products, (No Diag	Barone Francesca	MA	O	Chief Sc	S	-91	6.47	-14	-8	160	D
7/15/24 08:36	7/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Tyagarajan Seshu	MA	O	CTO	S	-80	5.97	-13	-8	161	D
7/15/24 08:35	7/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Tak Paul Peter	MA	DO	CEO	S	-121	5.97	-20	-5	353	D
7/15/24 08:34	7/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Schoch Charles	MA	O	See Rema	S	-53	5.97	-9	-11	72	D
7/15/24 08:32	7/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Nichols William Garrett	MA	O	Chief Me	S	-58	5.97	-10	-7	125	D
7/15/24 08:30	7/11/24	CADL	Health	BioPrd	Biological Products, (No Diag	Barone Francesca	MA	O	Chief Sc	S	-76	5.97	-13	-7	174	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person